The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells.

Application of autologous cells is considered for a broad range of regenerative therapies because it is not surrounded by the immunological and ethical issues of allo- or xenogenic cells. However, isolation, expansion, and application of autologous cells do suffer from variability in therapeutic efficacy due to donor to donor differences and due to prolonged culture. One important source of autologous cells is mesenchymal stromal cells (MSCs), which can differentiate toward endothelial-like cells, thus making them an ideal candidate as cell source for tissue vascularization. Here we screened MSCs from 20 donors for their endothelial differentiation capacity and correlated it with the gene expression profile of the whole genome in the undifferentiated state. Cells of all donors were able to form tubes on Matrigel and induced the expression of endothelial genes, although with quantitative differences. In addition, we analyzed the effect of prolonged in vitro expansion on the multipotency of human MSCs and found that endothelial differentiation is only mildly sensitive to expansion-induced loss of differentiation as compared to osteogenic and adipogenic differentiation. Our results show the robustness of the endothelial differentiation protocol and the gene expression data give insight in the differences in endothelial differentiation between donors.

[1]  H. Sung,et al.  In Situ Crosslinkable Gelatin Hydrogels for Vasculogenic Induction and Delivery of Mesenchymal Stem Cells , 2014, Advanced functional materials.

[2]  J. Fischer,et al.  Prostacyclin Suppresses Twist Expression in the Presence of Indomethacin in Bone Marrow-Derived Mesenchymal Stromal Cells , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[3]  P. Gervois,et al.  Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. , 2014, Pharmacology & therapeutics.

[4]  Austin Nuschke,et al.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing , 2014, Organogenesis.

[5]  Xu Cao,et al.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.

[6]  Lorenzo Moroni,et al.  Endothelial Differentiation of Mesenchymal Stromal Cells , 2012, PloS one.

[7]  M. Reinders,et al.  A Mesenchymal Stromal Cell Gene Signature for Donor Age , 2012, PloS one.

[8]  L. Stanton,et al.  Nanofiber topography and sustained biochemical signaling enhance human mesenchymal stem cell neural commitment. , 2012, Acta biomaterialia.

[9]  Michael J Davis,et al.  Spatial Distribution and Mechanical Function of Elastin in Resistance Arteries: A Role in Bearing Longitudinal Stress , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[10]  W. Jiang,et al.  αB-Crystallin, an Effector of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells , 2011, Molecular Cancer Research.

[11]  M. Volin,et al.  Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[12]  E. Wang,et al.  Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer , 2011, Cancer Immunology, Immunotherapy.

[13]  R. Jorissen,et al.  PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. , 2011, Cancer research.

[14]  J. Chien,et al.  HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. , 2011, Cancer research.

[15]  D. Miao,et al.  Sodium/myo‐inositol cotransporter 1 and myo‐inositol are essential for osteogenesis and bone formation , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Ju Chen,et al.  The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system. , 2011, Chang Gung medical journal.

[17]  E. Kremmer,et al.  Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII , 2011, Cancer Immunology, Immunotherapy.

[18]  Chunling Hu,et al.  Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: Associated signaling pathways, tumor phenotypes, and survival , 2011, Genes, chromosomes & cancer.

[19]  G. Mills,et al.  Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer , 2011, Journal of experimental & clinical cancer research : CR.

[20]  Carmen Koch,et al.  Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. , 2010, Cytotherapy.

[21]  Yang Bi,et al.  Mesenchymal stem cells: Molecular characteristics and clinical applications. , 2010, World journal of stem cells.

[22]  Y. Hsieh,et al.  Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. , 2010, European journal of cell biology.

[23]  T. Lehtimäki,et al.  Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques—Tampere Vascular Study , 2010, Annals of medicine.

[24]  L. Papucci,et al.  ζ‐Crystallin is a bcl‐2 mRNA binding protein involved in bcl‐2 overexpression in T‐cell acute lymphocytic leukemia , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  E. Zackai,et al.  Further evidence for the possible role of MEIS2 in the development of cleft palate and cardiac septum , 2010, American journal of medical genetics. Part A.

[26]  W. Aird,et al.  Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3. , 2010, Blood.

[27]  C. V. van Blitterswijk,et al.  Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. , 2010, Tissue engineering. Part A.

[28]  Lei Yuan,et al.  Differential roles for ETS, CREB, and EGR binding sites in mediating VEGF receptor 1 expression in vivo. , 2009, Blood.

[29]  C. V. van Blitterswijk,et al.  A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells , 2009, Journal of cellular and molecular medicine.

[30]  Clemens A van Blitterswijk,et al.  The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells , 2009, Acta orthopaedica.

[31]  G. Duda,et al.  Insights into Mesenchymal Stem Cell Aging: Involvement of Antioxidant Defense and Actin Cytoskeleton , 2009, Stem cells.

[32]  I. Shapiro,et al.  Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. , 2009, The Journal of surgical research.

[33]  E. Wang,et al.  Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. , 2009, European journal of cancer.

[34]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[35]  J. Graw.  Genetics of crystallins: cataract and beyond. , 2009, Experimental eye research.

[36]  W. Seeger,et al.  Fhl-1, a New Key Protein in Pulmonary Hypertension , 2008, Circulation.

[37]  S. Brennecke,et al.  Novel homeobox genes are differentially expressed in placental microvascular endothelial cells compared with macrovascular cells. , 2008, Placenta.

[38]  V. Beneš,et al.  Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process , 2008, PloS one.

[39]  C. V. van Blitterswijk,et al.  The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. , 2007, Current stem cell research & therapy.

[40]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  V. Serre-Beinier,et al.  Characterization of endothelial‐like cells derived from human mesenchymal stem cells , 2007, Journal of thrombosis and haemostasis : JTH.

[42]  Clemens A van Blitterswijk,et al.  A rapid and efficient method for expansion of human mesenchymal stem cells. , 2007, Tissue engineering.

[43]  G. Lepperdinger,et al.  Mesenchymal stem cell aging , 2005, Experimental Gerontology.

[44]  G. Watkins,et al.  The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. , 2005, International journal of oncology.

[45]  T. Suganuma,et al.  Beyond vasodilation: the antioxidant effect of adrenomedullin in Dahl salt-sensitive rat aorta. , 2005, Biochemical and biophysical research communications.

[46]  M. Hoshino,et al.  Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration , 2005, Science.

[47]  Q. Han,et al.  Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. , 2005, Biochemical and biophysical research communications.

[48]  W. Vaughn,et al.  Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model , 2005, Circulation.

[49]  Gordon K. Smyth,et al.  limmaGUI: A graphical user interface for linear modeling of microarray data , 2004, Bioinform..

[50]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[51]  Xiran Zhang,et al.  Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro , 2004, Experimental biology and medicine.

[52]  Christopher H Contag,et al.  Adipose-derived adult stromal cells heal critical-size mouse calvarial defects , 2004, Nature Biotechnology.

[53]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[54]  E. Falk,et al.  TDAG51 Is Induced by Homocysteine, Promotes Detachment-mediated Programmed Cell Death, and Contributes to the Development of Atherosclerosis in Hyperhomocysteinemia* , 2003, Journal of Biological Chemistry.

[55]  C. Kieda,et al.  IL-7 receptor is present on human microvascular endothelial cells. , 2003, Immunology letters.

[56]  E. H. Margulies,et al.  Gene expression in donor corneal endothelium. , 2002, Archives of ophthalmology.

[57]  S. Both,et al.  Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. , 2002, Tissue engineering.

[58]  D. Soligo,et al.  Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. , 2002, Experimental hematology.

[59]  Shulamit Levenberg,et al.  Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[61]  F. Luyten,et al.  Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. , 2001, Arthritis and rheumatism.

[62]  C. Meininger,et al.  Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine , 2001, Diabetologia.

[63]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[64]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[65]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[66]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[68]  P. Marie,et al.  Isolation and Characterization of Human Clonogenic Osteoblast Progenitors Immunoselected from Fetal Bone Marrow Stroma Using STRO‐1 Monoclonal Antibody , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  B. Clark,et al.  Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients , 1999, Mechanisms of Ageing and Development.

[70]  U. Sauer,et al.  Expression of Glutamine:Fructose-6-Phosphate Amidotransferase in Human Tissues: Evidence for High Variability and Distinct Regulation in Diabetes , 1998, Diabetes.

[71]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[72]  A. Hubel,et al.  Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. , 2015, Cytotherapy.

[73]  B. Clark,et al.  Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts , 2007, Osteoporosis International.

[74]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[75]  Nasim Akhtar,et al.  Angiogenesis assays: a critical overview. , 2003, Clinical chemistry.

[76]  A. Carr,et al.  Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. , 1998, Scandinavian journal of rheumatology.